Home
Conditions
Neoplasms, Connective and Soft Tissue

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,731 public trials 585 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Completed

Symphion® System In-Office Study

NCT02520414

Conditions: Connective Tissue Diseases, Endometrial Polyps, Myofibroma, +6 more
Locations: Center for Women's Surgery Albuquerque, New Mexico, United States

View Trial Details

Completed

A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas

NCT01140737

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom

Western General Hospital Edinburgh, Scotland, United Kingdom

Bristol Haematology & Oncology Centre Bristol, United Kingdom

St. James's Hospital Leeds, United Kingdom

View all 13 locations

View Trial Details

Completed

Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma

NCT00423618

Conditions: Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiopericytoma, Malignant, +26 more
Locations: Royal Orthopedic Hospital NHS Trust Birmingham, England, United Kingdom

Christie Hospital Manchester, England, United Kingdom

Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom

Nottingham City Hospital Nottingham, England, United Kingdom

View Trial Details

Completed

Case Collection Study in the Evaluation of Doubling Time Rates in Non-Suspicious Breast Masses Using QT Ultrasound Technology

NCT03470051

Conditions: Breast Fibroadenoma, Fibroadenoma, Neoplasms, +6 more
Locations: Memorial Care Long Beach Long Beach, California, United States

Marin Breast Health Trial Center Novato, California, United States

View Trial Details

Completed

Risk Factors for Non-HIV-Related Kaposi s Sarcoma

NCT00339326

Conditions: DNA Virus Infections, Herpesviridae Infections, Infections, +8 more
Locations: Universita Degli Studi Di Palermo Palermo, Italy

View Trial Details

Completed

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT03070951

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +16 more
Locations: Site reference ID 905 Chino, California, United States

Site reference ID 918 Huntington Park, California, United States

Site reference ID 902 San Diego, California, United States

Site reference ID 903 Denver, Colorado, United States

View all 96 locations

View Trial Details

Completed

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

NCT01276236

Conditions: DNA Virus Infections, Herpesviridae Infections, Infections, +8 more
Locations: San Francisco General Hospital, Clinical Trials Unit San Francisco, California, United States

View Trial Details

Completed

Trial of Afatinib in Pediatric Tumours

NCT02372006

Conditions: Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +7 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

The University of Texas Health Science Center at Houston Houston, Texas, United States

University of Wisconsin Madison, Wisconsin, United States

Sydney Childrens Hospital Randwick, New South Wales, Australia

View all 28 locations

View Trial Details

Completed

Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma

NCT00258687

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
Locations: Children's Hospital Boston Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas

NCT02448537

Conditions: Metastatic Sarcoma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Neoplasms, Connective and Soft Tissue

Neoplasms, Connective and Soft Tissue trial results

Related conditions